جستجوی استاد راهنمای دانشگاهی

Associate Professor Adam Irwin is an NHMRC Emerging Leadership Fellow and Associate Professor in Infectious Diseases at the University of Queensland (UQ) and Queensland Children’s Hospital. He holds positions within the UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences. His work focuses on early sepsis recognition, antimicrobial stewardship, and pediatric infectious diseases. Dr. Irwin completed his medical degree at the University of Birmingham and his PhD in 2016 from the University of Liverpool’s Institute of Infection and Global Health. He has led initiatives like the Queensland Paediatric Sepsis Program, recognized with a Global Sepsis Alliance Award and Queensland Health Excellence Awards. His research spans sepsis pathway implementation, antimicrobial resistance trends, and rapid diagnostic tools. Notable grants include NHMRC funding for studies on multi-drug resistant infections and Children’s Hospital Foundation support for genomics and antimicrobial stewardship projects. He supervises PhD candidates in areas like bloodstream infections and molecular diagnostics. Dr. Irwin collaborates across institutions, contributing to projects such as the RAPIDS Study Group and the PAEDS surveillance network. Awards include the NHMRC Emerging Leadership Fellowship and recognition for sepsis program excellence. His work emphasizes translating research into clinical practice, improving outcomes for critically ill children through evidence-based protocols and innovative diagnostics.

• Infectious Diseases
• Pediatric Medicine
• Antimicrobial Resistance
• +۳ مورد دیگر

Professor Jianhua Guo is a faculty member at The University of Queensland (UQ), holding the position of Professor and UQ Amplify Fellow in the Australian Centre for Water and Environmental Biotechnology (ACWEB). He is also the ACWEB Deputy Director - Research. His research focuses on integrating process engineering, environmental microbiology, and biotechnology to develop sustainable solutions for contaminant removal in water and wastewater systems. He is a pioneer in studying the environmental dimension of antimicrobial resistance (AMR), particularly how non-antibiotic pharmaceuticals and chemicals contribute to AMR spread. His groundbreaking work has been featured in over 100 media outlets and has secured over $14M in research funding. He has published over 200 peer-reviewed articles in journals like Nature Microbiology , Water Research , and Environmental Science & Technology . His accolades include the 2013 DECRA and 2017 ARC Future Fellowship. He serves as an editor for Journal of Hazardous Materials and Water Science & Technology . Research Interests Environmental AMR and microbial ecology Methane-based biotechnology and bioconversion Nitrogen cycling microorganisms Bioremediation and biofilm reactors Microplastics and health risks Wastewater treatment innovations Grants & Funding $14M+ in ARC Discovery/Linkage grants and industry partnerships ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance (CEA-StAR) Dual-membrane upgrading and anaerobic alkane oxidation projects Awards 2013 DECRA 2017 ARC Future Fellowship Supervision Prof. Guo actively supervises PhD and master’s students in areas like AMR mitigation, methane-based bioreactors, and microbial ecology. Notable supervised projects include studies on antibiotic resistance in wastewater, novel disinfection processes, and microbial oxidation of gaseous alkanes. Labs & Teams He leads research teams within ACWEB and collaborates with the Queensland Alliance for Environmental Health Science. His lab focuses on cutting-edge technologies like membrane biofilm reactors and gas fermentation systems.

• Environmental Biotechnology
• Antimicrobial Resistance (AMR)
• Wastewater Treatment
• +۷ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

David Blair is a Professor at James Cook University, specializing in parasitic flatworms, molecular systematics, and evolutionary biology. His research focuses on understanding the genetic diversity, phylogeography, and host-parasite interactions of species such as Schistosoma, Paragonimus, and Opisthorchis. He has contributed extensively to studies on the molecular evolution of parasitic organisms and their implications for human and wildlife health. Key research areas include: molecular taxonomy of trematodes, phylogenetic analysis of parasitic flatworms, and genomic studies of host-parasite coevolution. Collaborations span global institutions, addressing public health challenges like paragonimiasis and fasciolosis. His work integrates field studies, lab-based molecular techniques, and computational biology to unravel evolutionary dynamics and ecological adaptations. Recent studies focus on the genetic diversity of Daphnia species, dugong population genetics, and drug-resistant Mycobacterium tuberculosis. His publications in journals like *Parasitology*, *Molecular Phylogenetics and Evolution*, and *Scientific Reports* highlight interdisciplinary approaches to parasitology and conservation biology.

• Parasitology
• Molecular Biology
• Phylogenetics
• +۵ مورد دیگر

Dist. Professor Rachel Caruso is a Professor at RMIT University's School of Science, specializing in nanomaterials, energy storage systems, and photocatalysis. Her research focuses on advancing materials science through innovations in titanium-based nanomaterials, perovskite solar cells, and sustainable hydrogen production. She is actively involved in research supervision, offering guidance on topics like carbon capture, electrochemical CO₂ reduction, and antimicrobial surface engineering. Her work integrates machine learning for material discovery and emphasizes interdisciplinary applications in environmental and biomedical fields. Research Interests: Macromolecular Chemistry, Nanotechnology, Energy Materials, Photocatalysis, and Biomedical Applications. Supervision Projects: Includes pioneering studies on direct air capture of CO₂, graphene-based photocatalytic films, and perovskite materials for biomedical uses. Professor Caruso collaborates extensively on projects addressing global challenges such as renewable energy and antimicrobial resistance. Her contributions span over 200 publications, with notable advancements in titanium suboxide synthesis and electrocatalyst design.

• Macromolecular and Materials Chemistry
• Physical Chemistry (incl. Structural)
• Nanotechnology
• +۳ مورد دیگر

Professor Hak-Kim Chan of the Sydney Pharmacy School at the University of Sydney is a world-renowned expert in respiratory drug delivery, particularly pulmonary aerosols and inhalation therapies. With over 480 publications and 17,580+ Google Scholar citations, he has pioneered advancements in powder formulation , in silico modeling , and clinical applications of inhalation technologies. His work includes the development of FDA-approved diagnostics like Aridol™ (inhaled mannitol for asthma) and Bronchitol™ (for cystic fibrosis), and groundbreaking research on inhaled bacteriophage therapy to combat antibiotic-resistant respiratory infections. Education: BPharm (University Medal, 1983), PhD (1988), DSc (2009) from University of Sydney Professional Experience: Postdoc at University of Minnesota (1988–89), Scientist at Genentech Inc. (1992–95) Leadership: Executive Editor of Advanced Drug Delivery Reviews , Fellow of AAPS and RACI His research spans in vitro production methods, computational modeling of inhaler design, and in vivo imaging of aerosol deposition. Current projects focus on nanomedicine , phage therapy , and combating superbugs via inhalation routes. He has secured significant recognition for his work, including NHMRC case studies highlighting public health impacts. Professor Chan has supervised numerous researchers, including PhD student Grace YAU studying pulmonary probiotic delivery . His team's 10 patents (7 as first inventor) reflect practical innovations in dry powder inhalers , antimicrobial formulations , and drug stabilization technologies.

• Respiratory Drug Delivery
• Pulmonary Drug Delivery
• Inhalation Aerosols
• +۵ مورد دیگر

Associate Professor Gilda Carvalho is a leading researcher at the Australian Centre for Water and Environmental Biotechnology (ACWEB) and the School of Chemical Engineering at the University of Queensland. She leads the Drinking and Recycled Water research group and specializes in Environmental Bioengineering , focusing on microbial processes for water/wastewater treatment and resource recovery. Research areas: Chemicals of Emerging Concern (CEC), Biological Nutrient Removal (BNR), biofilm systems, membrane processes, and polyhydroxyalkanoate (PHA) production Key methodologies: Molecular tools linking microbial ecology to process performance Academic output: Over 90 peer-reviewed papers and >40 multinational research projects with industrial partners Educational impact: Coordinator of Postgraduate Programs in Urban Water Engineering and supervisor of >20 PhD students Her recent research explores phage-based biofilm disruption , micropollutant removal via advanced oxidation, and resource recovery from waste streams. Current funding includes projects on biofilm solutions for drinking water and sustainable wastewater reuse. She integrates multidisciplinary approaches across biotechnology, chemical engineering, and environmental science to address global water challenges.

• Environmental Engineering
• Bioprocess Engineering
• Microbial Ecology
• +۹ مورد دیگر

Carmen Huckel Schneider is an Associate Professor at the University of Sydney, holding positions as Deputy Director of the Leeder Centre for Health Policy, Economics and Data and Director of Academic Education in the Sydney School of Public Health. She also serves as Honorary Senior Fellow at the George Institute and Senior Adviser at the Sax Institute. Her research focuses on global health governance, health policy analysis, and health systems financing. She completed her PhD at the University of Tübingen, examining global health organizations' legitimacy. Her current research explores governance in global health, comparative health systems analysis, and systems approaches to health policy. She leads the Health Governance, Policy and Leadership theme at the Leeder Centre and coordinates units on 'Health Systems and Financing' and 'Global Health Policy'. Notable grants include NHMRC Partnership Grants for health system reforms in NSW and a Centre for Research Excellence in Integrating Health and Social Care. She collaborates internationally, including with the University of Geneva on projects analyzing global health security discourses. Her publications span global health governance, health system reforms, and policy frameworks. She has authored books like *The Legitimacy of Global Health Governance* and contributed to high-impact journals such as *The Lancet Regional Health* and *BMJ Global Health*.

• Global Health
• Health Policy
• Health Governance
• +۴ مورد دیگر

Professor Hilary Bambrick is a distinguished environmental epidemiologist and anthropologist at the Australian National University (ANU), leading the National Centre for Epidemiology and Population Health. She specializes in climate change and health, focusing on adaptation strategies, vector-borne diseases, and urban resilience. Her work bridges research, policy, and practice, with significant contributions to global health initiatives like the WHO and UNDP. Bambrick has over 180 publications and $11M in research funding, addressing climate impacts on vulnerable populations, including First Nations communities and Pacific Island nations. She serves on the Climate Council of Australia and the Australia Institute, advocating for evidence-based climate policies. Her research integrates epidemiology, anthropology, and environmental science to enhance health resilience in changing climates. Education: PhD (ANU, 2003), BA (Hons), BSc, Grad Cert Higher Ed. Key Research Focus: Climate change health impacts, adaptation strategies, vector-borne diseases, urban design, and health equity. She leads interdisciplinary projects on climate litigation, heatwaves, and infectious disease forecasting. Grants & Funding: Over $11 million in research grants, including projects on bushfire preparedness, dengue transmission modeling, and climate-sensitive disease surveillance. Labs/Teams: National Centre for Epidemiology and Population Health (ANU), collaborating with global networks like the Lancet Countdown and MJA-Lancet Countdown.

• Climate Change and Health
• Environmental Epidemiology
• Public Health Policy
• +۵ مورد دیگر

Professor Ravi Shukla is a faculty member at RMIT University's School of Science, holding the title of Professor and Deputy Head of Department (Research). He specializes in Nanobiotechnology, with research spanning biomaterials, drug delivery systems, and medical diagnostics. His work integrates biosciences, materials science, and food technology to advance understanding of nanomaterial-biomolecular interactions. Academic History: Professor Shukla has held roles at RMIT since 2011, progressing from Research Fellow to his current professorship. He also serves as an Adjunct Professor at the University of Missouri and Theme Leader for Nanobiotechnology at RMIT’s Center for Advanced Materials and Industrial Chemistry. His teaching focuses on fostering student belonging and innovation in biotechnology education, including coordinating RMIT’s undergraduate Biotechnology program. Research Interests: His lab explores hybrid biomaterial synthesis, nano-enabled proteomics, and non-viral gene therapy using MOFs. Recent work emphasizes applications in diabetes biosensing, CRISPR/Cas9 delivery, and antimicrobial resistance mitigation through nanostrategies. Over 130+ publications and substantial research funding highlight his interdisciplinary impact. Professional Engagement: Editor roles in Frontiers in Bioengineering and Biotechnology , Co-Editor-in-Chief of Current Research in Nutrition and Food Science , and advisor to the Australasian Association of Ayurveda underscore his leadership. He actively mentors students in projects like nano-antimicrobial wound healing and aptamer-based hepatitis A detection. Key Achievements: Pioneered nucleic acid-encapsulated MOFs for cancer therapy and developed paper-based biosensors for rapid diagnostics. His work aligns with UN Sustainable Development Goals 2 (Zero Hunger) and 3 (Good Health).

• Nanobiotechnology
• Bioscience
• Medical Biotechnology
• +۶ مورد دیگر

Dr. Suman Adhikari is a Conjoint Lecturer at the School of Clinical Medicine , University of New South Wales (UNSW), focusing on Infectious Diseases , Antimicrobial Stewardship , and Clinical Pharmacology . He has contributed to advancements in antibiotic management, sepsis diagnostics, and e-learning tools for healthcare professionals. University: University of New South Wales School: School of Clinical Medicine Email: suman.adhikari@unsw.edu.au Research Interests: Dr. Adhikari’s work spans antimicrobial stewardship in tertiary care, therapeutic drug monitoring of antibiotics like linezolid, and educational technology for vancomycin use. He also explores pharmacokinetics in parasitic infections and contributes to sepsis pathway optimization . Publication Trends: His recent articles (2017–2023) highlight antibiotic safety , digital education , and infection control . Notable studies include multimodal stewardship in ICU, qSOFA criteria validation, and e-learning tool efficacy for vancomycin training. Contact: Phone: 0411817996 | Location: Gray Street, Kogarah 2217 NSW

• Infectious Diseases
• Antimicrobial Stewardship
• Clinical Pharmacology
• +۶ مورد دیگر

Dr. Alicia Fajardo Lubian serves as a Research Fellow at the Westmead Clinical School within the University of Sydney's Faculty of Medicine and Health. Her work bridges bacteriophage therapy, antimicrobial resistance, and gut microbiome dynamics, with a focus on translating research into clinical solutions for infectious diseases. Her research explores the interplay between bacteriophages and human immunity, antibiotic effects on microbial communities, and molecular mechanisms of pathogen evolution. She employs genomic and experimental approaches to investigate Klebsiella pneumoniae, Escherichia coli, and phage-based therapeutics. Publications spanning 2014-2025 demonstrate concentrated expertise in antimicrobial resistance surveillance (e.g., AGAR reports), phage-immune interactions, and microbiome disruption models. Over 85% of articles involve international collaborations, reflecting strong engagement with global health challenges. Awards: EMCR Emerging Star Funding (2022) Grant involvement includes the 2022 EMCR Emerging Star Funding from the Faculty of Medicine and Health, supporting innovative research in phage therapeutics.

• Bacteriophage Therapy
• Antimicrobial Resistance
• Gut Microbiota
• +۳ مورد دیگر

Professor Trevor Lithgow is a Research Professor in Microbiology at Monash University, affiliated with the Monash Biomedicine Discovery Institute. He holds a PhD from La Trobe University (1992) and has held fellowships including the ARC Federation Fellowship (2008) and ARC Laureate Fellowship (2014). His research focuses on bacterial cell biology, antimicrobial resistance (AMR), and phage therapies, leveraging nanoscale imaging techniques like cryo-EM and super-resolution microscopy. He leads the Monash Centre to Impact AMR, an interdisciplinary initiative addressing global AMR challenges through collaborations across engineering, social sciences, and clinical medicine. Key achievements include the HFSP Tenth Anniversary Award (1999), Lemberg Medal (2020), and Royal Society of Victoria Medal (2017). His work on bacterial outer membrane assembly, phage-bacteria interactions, and structural analysis of the mitochondrial TOM complex has advanced understanding of pathogen resilience and novel antimicrobial strategies. Current projects include developing phage therapies and cross-sectoral AMR surveillance frameworks. Education: PhD in Biochemistry (La Trobe University, 1992) Research Interests: Bacterial cell surface visualization, nanoscale imaging, phage biology, AMR mechanisms Leadership: Director of Monash Centre to Impact AMR since 2020 Awards: 10+ national/international honors, including ARC Fellowships Publications span over 250 articles on bacterial membrane biology, AMR dynamics, and phage applications, with recent focus on polymyxin dependence in Acinetobacter and phage-driven resistance resensitization.

• Antimicrobial Resistance
• Bacterial Cell Biology
• Membrane Biochemistry
• +۵ مورد دیگر

Professor Chris Greening is a Research Professor in the Department of Microbiology at Monash University, leading the One Health Microbiology group at the Biomedicine Discovery Institute. He holds a first-class degree in Molecular and Cellular Biochemistry from the University of Oxford (2010) and a PhD from the University of Otago (2013). His career includes postdoctoral roles at Otago, CSIRO, and the Australian National University, followed by appointments as a group leader in Monash’s School of Biological Sciences (2016) and a medically-focused NHMRC EL2 Fellow in the Department of Microbiology (2020). Research Focus: Bacterial persistence mechanisms, microbial metabolism, antimicrobial resistance (AMR), and One Health approaches linking environmental, clinical, and public health challenges. Awards: Fenner Medal (2022) and Jim Pittard Award (2019). Key Projects: RISE, Global Research Alliance on Agricultural GHGs, SAEF, and the ARC Carbon Utilisation Hub. Leads Monash’s AMR R&D Facility. Research spans metabolic pathways enabling bacterial survival in extreme conditions (e.g., hydrogen oxidation, F420 cofactor roles), climate impacts (greenhouse gas regulation), and translational programs addressing diarrheal diseases and AMR. Grants: ARC DECRA Fellowship, NHMRC EL2 Fellowship. Cross-disciplinary collaborations with engineers, ecologists, social scientists, and industry. Lab facilities include advanced microbiology, structural biology, and systems biology tools. Contributions align with UN SDGs: climate action (SDG13), good health (SDG3), and sustainable cities (SDG11).

• Microbial Metabolism
• Antimicrobial Resistance
• Environmental Microbiology
• +۵ مورد دیگر

Vijini Mallawaarachchi is a Research Fellow in Bioinformatics at Flinders University's Flinders Accelerator for Microbiome Exploration (FAME). His research focuses on developing computational methods for metagenomic analysis, particularly viral genome recovery from metagenomes. He holds a PhD in Computer Science from the Australian National University (2022) and a BSc in Computer Science and Engineering (Honours) from the University of Moratuwa, Sri Lanka (2018). Education: Doctor of Philosophy (Computer Science), Australian National University, 2018–2022 Bachelor of Science (Computer Science & Engineering, Honours), University of Moratuwa, 2014–2018 Research Interests: Metagenomics, algorithms for genome recovery, bacteriophage discovery, machine learning applications in bioinformatics, and software engineering for computational biology. His work emphasizes leveraging assembly graphs and computational models to analyze microbial communities and viral genomes. Grants & Awards: 2025: National Computational Merit Allocation Scheme Grant (Co-CI) - A$412,000 2025: ARC Discovery Projects Grant (Co-CI) - A$685,781 2024: Outstanding PhD Thesis Award (ABACBS) 2023: Australian Society for Microbiology Early Career Award Professional Engagement: Active member of ISMB, ISVM, ACM, IEEE, ABACBS, ASM, and RSE AU/NZ. Supervises HDR and Honours students in bioinformatics and computational biology. Labs & Tools: Leads projects at FAME, developed tools like GraphBin, Phables, and ConDiGA for metagenomic analysis. Collaborates on open-source initiatives like the cogent3 Python APIs.

• Metagenomics
• Bioinformatics
• Bacteriophages
• +۳ مورد دیگر